Abstract
Osteosarcoma (OSA) is a type of bone cancer that begins in the cells that form bones.OSA is a rare mesenchymal bone neoplasm derived from mesenchymal stem cells. Genome disorganization, chromosomal modifications, deregulation of tumor suppressor genes, and DNA repair defects are the factors most responsible for OSA development. Despite significant advances in the diagnosing and treatment of OSA, patients’ overall survival has not improved within the last twenty years. Lately, advances in modern nanotechnology have spurred development in OSA management and offered several advantages to overcome the drawbacks of conventional therapies. This technology has allowed the practical design of nanoscale devices combined with numerous functional molecules, including tumor-specific ligands, antibodies, anti-cancer drugs, and imaging probes. Thanks to their small sizes, desirable drug encapsulation efficiency, and good bioavailability, functionalized nanomaterials have found wide-spread applications for combating OSA progression. This review invokes the possible utility of engineered nanomaterials in OSA diagnosis and treatment, motivating the researchers to seek new strategies for tackling the challenges associated with it.
Highlights
Osteosarcoma (OSA) is the most common primary metastatic bone cancer in children, young adults, and sometimes in elderlies [1]
Thousands of nanocarriers have reached the clinic, and there are hundreds of nanomaterials proposals being tested by the Food and Drug Administration (FDA) [61,62]
The finding of this study indicated that albumin-based nanomaterials would provide a system for bone imaging and evaluation
Summary
Osteosarcoma (OSA) is the most common primary metastatic bone cancer in children, young adults, and sometimes in elderlies [1]. Different imaging techniques, including X-ray computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), are widely used for detecting primary and secondary OSA tumors [10,11]. Among these techniques, CT is mostly preferred for skeletal system diseases, since MRI is not sensitive to calcium-enriched bone tissues, and PET scanning has low spatial resolution [12]. Nanoparticles (NPs) have wide-spread applications in OSA diagnosis and treatment [24,25]. Due to their targeting capacity and tumor aggregation, functional nanostructures can improve X-ray contrast and detection sensitivity
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
